Marvin Samson, Director at ANTARES PHARMA, INC. (ATRS), sold 150,000 shares at $4.71 ($707K) on 2019-12-23, disclosed to the SEC on 2019-12-26.
Open-market sale of $706k ATRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRS | BUY | 2016-03-21 | $36K | — | Filing → |
| ATRS | BUY | 2014-08-12 | $50K | — | Filing → |